
Indian drug manufacturer has begun production of the Russian Sputnik V coronavirus vaccine, the Russian Direct Investment Fund (RDIF), responsible for marketing the shot internationally, said on Tuesday.
The first test batch made by the Indian manufacturer in the state of Himachal Pradesh will be shipped to Gamaleya, the Moscow institute which developed the vaccine, for quality controls, RDIF said in a statement.
The first test batch made by the Indian manufacturer in the state of Himachal Pradesh will be shipped to Gamaleya, the Moscow institute which developed the vaccine, for quality controls, RDIF said in a statement.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.